FGFR2 and cancer: FGFR2 extracellular domain in-frame deletions are known to cause autosomal dominant congenital craniosynostosis syndromes during growth [26–29] and cause oncogenicity during cancer development in ICC [15], whereas the function of FGFR2 TK domain deletions was not known until now.